Recent Quotes

My Watchlist

Indicators

Overview

Currencies

International

Treasuries

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP

Today 12:53 EST

Via PRLog

1 Reason I'd Buy Eli Lilly Stock and Never Sell ↗

Today 12:35 EST

Via The Motley Fool

HRMY Stock Rises On Fresh FDA Approval For Wakix Tablets In Children But Wall Street Eyes Further Rally ↗

Today 12:17 EST

Via Stocktwits

The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot

Today 12:04 EST

Via MarketMinute

Universal Wellness Roscoe Village’s Chicago Chiropractic Office Reaches 392 Google Reviews with a 4.9-Star Rating

Today 12:02 EST

Via Press Advantage

Why Did Compass Pathways Stock Rocket Higher Today? ↗

Today 11:55 EST

Via The Motley Fool

Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner ↗

Today 11:45 EST

Via Benzinga

Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk ↗

Today 11:04 EST

Via Investor's Business Daily

Medtronic (MDT) Q3 2026 Earnings Call Transcript ↗

Today 10:50 EST

Via The Motley Fool

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRX-100 NDA Pathway

Today 10:31 EST

Via Investor Brand Network

Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline

Today 10:06 EST

Via Finterra

Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot

Today 9:57 EST

Via Finterra

Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum

Today 9:45 EST

Via Finterra

Shopify's Whiplash Day ↗

Today 9:31 EST

Via The Motley Fool

Federal Health Expert Launches Telehealth Platform That’s Disrupting the $75+ Online Doctor Visit

Today 9:16 EST

Via AB Newswire

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Today 8:00 EST

Via Newsfile

NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026

Today 7:30 EST

Via NewMediaWire

NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026

Today 7:30 EST

Via TheNewswire.com

FDA Delays Disc Medicine's Rare Disease Drug ↗

Today 5:54 EST

Via Benzinga

CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗

Today 5:49 EST

Via Stocktwits

The Top 5 Analyst Questions From Incyte’s Q4 Earnings Call

Today 0:32 EST

Via StockStory

Anktiva Vs Keytruda: ImmunityBio Exec Chair Slams FDA For Double Standards In Approvals ↗

Today 0:31 EST

Via Stocktwits

OCUL Stock Surges Overnight Ahead Of Crucial Wet AMD Data Readout, Sanofi Takeover Buzz Builds ↗

February 16, 2026

Via Stocktwits

Robert Kennedy Jr Says FDA Lost Track Of Food Ingredients, No Way For Americans To Know If 'Ultra Processed' Food Safe ↗

February 16, 2026

Via Benzinga

Matthew West-James’ new book receives a warm literary welcome

February 16, 2026

Via Get News

ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards

February 16, 2026

Via MarketMinute

Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom

February 16, 2026

Via MarketMinute

Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data

February 16, 2026

Via MarketMinute

Got $300? 2 Biotech Stocks to Buy and Hold Forever ↗

February 16, 2026

Via The Motley Fool

FDA Detects Toxic Patulin Levels In Tippy Toes Baby Food, Prompting Recall ↗

February 15, 2026

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.